Cargando…

A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia

Schizophrenia is a neuropsychiatric disorder characterized by various symptoms including autonomic imbalance. These disturbances involve almost all autonomic functions and might contribute to poor medication compliance, worsened quality of life and increased mortality. Therefore, it has a great impo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Büki, Alexandra, Kekesi, Gabriella, Horvath, Gyongyi, Vécsei, László
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467675/ https://www.ncbi.nlm.nih.gov/pubmed/34576179 http://dx.doi.org/10.3390/ijms221810016

Ejemplares similares

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
por: Zádor, Ferenc, et al.
Publicado: (2019)

Caffeine-Induced Acute and Delayed Responses in Cerebral Metabolism of Control and Schizophrenia-like Wisket Rats
por: Horvath, Gyöngyi, et al.
Publicado: (2022)

Sleep-Wake Rhythm and Oscillatory Pattern Analysis in a Multiple Hit Schizophrenia Rat Model (Wisket)
por: Adlan, Leatitia Gabriella, et al.
Publicado: (2022)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression
por: Zádor, Ferenc, et al.
Publicado: (2021)

Abnormal Motor Activity and Thermoregulation in a Schizophrenia Rat Model for Translational Science
por: Horvath, Gyongyi, et al.
Publicado: (2015)

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
por: Török, Nóra, et al.
Publicado: (2020)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
por: Boros, Fanni A., et al.
Publicado: (2019)

Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
por: Rajda, Cecilia, et al.
Publicado: (2015)

The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing
por: Török, Nóra, et al.
Publicado: (2015)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
por: Sas, Katalin, et al.
Publicado: (2018)

Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
por: Nagy-Grócz, Gábor, et al.
Publicado: (2017)

Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines
por: Fakan, Bernadett, et al.
Publicado: (2019)

Imbalanced Kynurenine Pathway in Schizophrenia
por: Kegel, Magdalena E, et al.
Publicado: (2014)

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
por: Tanaka, Masaru, et al.
Publicado: (2020)

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
por: Zádori, Dénes, et al.
Publicado: (2011)

Quercetin Caused Redox Homeostasis Imbalance and Activated the Kynurenine Pathway
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2020)

Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders
por: Myint, Aye-Mu, et al.
Publicado: (2022)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Potential drug targets in the kynurenine pathway to treat acute schizophrenia
por: Malhotra, Ayush, et al.
Publicado: (2021)

Cluster headache and kynurenines
por: Tuka, Bernadett, et al.
Publicado: (2023)

Effects of inflammation on the kynurenine pathway in schizophrenia — a systematic review
por: Pedraz-Petrozzi, Bruno, et al.
Publicado: (2020)

Interaction of clozapine with metformin in a schizophrenia rat model
por: Horvath, G., et al.
Publicado: (2021)

Editorial: Multiple Implications of the Kynurenine Pathway in Inflammatory Diseases: Diagnostic and Therapeutic Applications
por: Mándi, Yvette, et al.
Publicado: (2022)

Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
por: Fejes, Annamária, et al.
Publicado: (2011)

Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
por: Sandi, Dániel, et al.
Publicado: (2021)

The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
por: Nagy-Grócz, Gábor, et al.
Publicado: (2017)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Corrigendum: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
por: Nagy-Grócz, Gábor, et al.
Publicado: (2020)

Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
por: Tanaka, Masaru, et al.
Publicado: (2022)

Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
por: Rajda, Cecilia, et al.
Publicado: (2020)

Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
por: Won, Eunsoo, et al.
Publicado: (2016)

Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
por: Stone, Trevor W., et al.
Publicado: (2023)

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period
por: Tuka, Bernadett, et al.
Publicado: (2021)

PPARs and the Kynurenine Pathway in Melanoma—Potential Biological Interactions
por: Walczak, Katarzyna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jdoea085jpil9on8k5lt3qsp33